Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
IAG933 for Mesothelioma
Recruiting1 awardPhase 1
Baltimore, Maryland
This trial tests a new drug called IAG933 in patients with specific types of tumors. It aims to find the safest and most effective dose and see if the drug can help shrink the tumors.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service